Viral cardiomyopathy: Causes, diagnosis and treating — Mayo Clinic

Overview

Daniel S. Yip, M.D., transplant cardiologist and director of heart failure and heart transplant at Mayo Clinic's campus in Florida, talks about the causes, diagnosis and treatments of viral cardiomyopathy.

Published

July 9, 2013

Created by

Related Videos

Responding to successive waves of the coronavirus in a Singapore academic medical center — Mayo Clinic Cardiovascular Grand Rounds COVID-19 Series — Part 3

Paul Ananth Tambyah, M.D., National University Hospital, Singapore, discusses patient presentations of COVID-19 in Singapore and evolving care options for treating patients.

Mayo Clinic's approach to the arterial switch operation

Elizabeth H. Stephens, M.D., Ph.D., a Mayo Clinic congenital heart surgeon, demonstrates her technique in the arterial switch operation

Lessons from China on critical care considerations and staff safety during COVID-19 - Mayo Clinic Cardiovascular Grand Rounds COVID-19 Series — Part 1

CV Grand Rounds video presents two guest faculty from China who share their experiences in treating critical patients with COVID-19.

Behavior modification in treatment of atrial fibrillation

Mayo Clinic electrophysiologist Suraj Kapa, M.D., and preventive cardiologist Francisco Lopez-Jimenez, M.D., discuss the use of behavioral modifications for treatment of atrial fibrillation.

CV Grand Rounds — The Fontan operation: Unanticipated consequences

Mayo Clinic cardiologist, Alexander C. Egbe, M.B.B.S., discusses the unanticipated consequences of the Fontan operation. Fontan is a surgical procedure used in patients who are born with single ventricle physiology.

Hypertrophic cardiomyopathy and treatment options

Mayo Clinic heart specialists describe contemporary clinical and surgical management of hypertrophic cardiomyopathy (HCM).

Diagnosis and treatment of adult congenital heart disease

Mayo Clinic heart specialists discuss optimal management of congenital heart disease in adult patients.

Plasma ceramides — A novel biomarker of unstable atherosclerotic cardiovascular disease

Jeffrey W. (Jeff) Meeusen, Ph.D., discusses studies of plasma ceramides in three different patient populations.

Severe calcific mitral valve stenosis

Sameh M. Said, M.D., M.B., B.Ch., a cardiovascular surgeon at Mayo Clinic's campus in Rochester, Minnesota, discusses surgical treatment options for severe calcific mitral valve stenosis. Mitral valve surgery in the presence of severe ...